Author:
Murray John,Samarani Emanuela,Renica Chiara,Agreiter Iris,Orlando Laura,Hutt Daphna
Abstract
AbstractDespite improvements over the past several decades, infection remains a significant risk to all haematological patients receiving therapy. Those requiring allogeneic transplant and especially those that have HLA disparity or T-cell-depleted grafts have an even higher risk of infective complications due to delayed recovery of T- and B-cell function. Patients receiving CAR-T therapy also present unique problems related to their B cell aplasia. Early identification with prompt effective treatment is paramount to improve all patients’ survival. The recent pandemic has further highlighted patient safety through robust adherence to hand hygiene and maintenance of the environment with cleaning and disinfection as the backbone of an effective infection preventative program. Basic nursing care and a sound knowledge base of the risks, presentation, diagnosis and treatment will improve patient care.
Funder
European Society for Blood and Marrow Transplantation
Publisher
Springer International Publishing